why choose us

First received: June 08, 2023

Clinical Trial: A Study to Learn About the Study Medicine (PF-07293893) at Different Dose Levels in Healthy Adults

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: A PHASE 1, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO CONTROLLED, 4-PERIOD, CROSSOVER, FIRST-IN-HUMAN STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SINGLE ASCENDING ORAL DOS

Brief Summary: The purposes of the study are:To learn about the safety and tolerability of study medicine (PF-07293893).Tolerability is the extent to which side effects can be tolerated.Side effects are unwanted reactions to the study medicine.To measure the amount of PF-07293893 in blood after the medicine is taken by mouth.The study is seeking participants who:Are females of non-childbearing potential and males 18 to 65 years of ageAre in generally healthy conditionHave not had viral infections (HIV, HBV or HCV).HIV, human…

Read more